Hyperbolic tapering is a way of coming off an antidepressant in which each reduction is smaller than the last, so that the final steps — from a low dose down to nothing — are the smallest of all. The name comes from the shape of the relationship between dose and effect: it is a curve, not a straight line, and it flattens out at higher doses. Reducing in equal steps therefore removes a little effect early on and a great deal at the end, which is why so many people find the first cuts easy and the last ones miserable. Hyperbolic tapering matches the size of each step to the shape of that curve.
We plan every supervised taper at NCNE this way. This post explains the idea in plain terms, what it does and does not mean for someone coming off an SSRI, and why it is not a schedule you can look up.
Why is the dose–effect relationship a curve?
SSRIs such as sertraline, escitalopram and fluoxetine work by occupying the serotonin transporter, the protein that clears serotonin from the gap between nerve cells. Brain imaging studies have measured how much of that transporter is occupied at different doses, and the pattern is consistent: a low dose already occupies a large share, and each further increase adds less and less. Doubling a dose does not double the effect; it adds a modest amount to something that was already mostly there.
The same curve runs in reverse when a medication is reduced. Cutting a high dose in half removes a small slice of transporter occupancy. Cutting a low dose in half removes a much larger slice, and the step from the lowest tablet strength to zero removes the largest slice of all. In 2019, Mark Horowitz and David Taylor set this out in the Lancet Psychiatry and drew the practical conclusion: to produce an even, tolerable reduction in effect, the dose has to come down in steps that get smaller and smaller as it approaches zero — a hyperbolic pattern, rather than a linear one.
What goes wrong with the usual way of stopping?
The conventional approach has been to halve the dose, hold for a couple of weeks, then stop. Measured against the curve, that is two very unequal steps: a small one followed by an enormous one. Many people tolerate the first and are floored by the second, and the symptoms that follow — dizziness, nausea, flu-like feelings, irritability, disturbed sleep, vivid dreams and the electric-shock sensations known as brain zaps — are then read as proof that they “still need” the medication. Sometimes that is true. Often it is discontinuation syndrome, produced by the size of the step rather than by any return of the original illness.
Guidance has moved. The UK’s National Institute for Health and Care Excellence now recommends that antidepressants be stopped slowly, in stages, with the reductions becoming proportionally smaller as the dose gets lower, and that the pace be set by how the person is doing rather than by a fixed timetable. That is hyperbolic tapering by another name.
How small do the final steps get?
Smaller than tablets allow. The last stages of a hyperbolic taper involve doses well below the smallest strength most antidepressants are manufactured in, which is why liquid forms, split tablets or compounded doses come into it. Sertraline and escitalopram both come as oral liquids, which makes precise small steps practical; for other medications a switch to a longer-acting antidepressant such as fluoxetine is sometimes used to smooth the end of the process. Which of those applies depends on the medication, the dose and the person, which is the first reason we do not publish taper schedules.
How long does a hyperbolic taper take?
Longer than two weeks, and there is no honest single answer beyond that. Someone who has taken an SSRI for a few months at a low dose may need only a few weeks. Someone who has taken one for years, or who has had withdrawal symptoms on a previous attempt, may need many months, with pauses along the way. The pace is set by the response to each step: if a reduction produces symptoms, the step was too large, and the answer is to hold or go back rather than to push through. That is the second reason a taper is a plan revised at each visit rather than a calendar handed over at the first one.
Is hyperbolic tapering the same as “tapering slowly”?
It is more specific than that. A slow taper in equal steps still ends with the same large final drop; it just arrives later. Hyperbolic tapering changes the shape of the reduction, not only its length: early steps can be relatively generous, and the schedule spends most of its care at the low end where the curve is steepest. In practice a well-designed taper is both slow and hyperbolic, but it is the second property that prevents the crash at the end.
How do you tell withdrawal from relapse during a taper?
Timing, symptom type and response to a small dose change. Discontinuation symptoms usually appear within days of a reduction, include physical features such as dizziness, nausea or brain zaps, and settle quickly if the previous dose is briefly restored. A genuine return of depression or anxiety builds over weeks, looks like the original illness, and does not shift with a small adjustment. Making that distinction correctly is the main reason to taper under supervision rather than alone: acted on the wrong way, withdrawal gets treated as relapse and a medication that could have been stopped is restarted indefinitely.
Who is hyperbolic tapering for?
Anyone coming off an SSRI or SNRI, but it matters most for people who have taken one for a long time, who are on a short-acting medication such as venlafaxine or paroxetine, or who have tried to stop before and could not. It is not a reason to stop an antidepressant that is working; the decision to come off is separate from the method, and for many people staying on is the right choice. NCNE offers supervised antidepressant tapering by telehealth for adults in Connecticut, Massachusetts, New Hampshire, Maine, Rhode Island, Virginia and Kentucky, with separate pages on tapering off Lexapro and tapering off Zoloft. We do not taper benzodiazepines.
Do not reduce or stop an antidepressant on your own on the strength of this post. It is general information, not a plan; the plan has to be built around your medication, your dose and your history, by the prescriber who knows them. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline) or call 911.
Sources
- Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019;6(6):538–546. PubMed
- National Institute for Health and Care Excellence. Depression in adults: treatment and management (NG222). 2022. nice.org.uk